Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital.
- Author:
Xuelin LI
1
;
Jinfa TANG
;
Fei MENG
;
Chunxiao LI
;
Yanming XIE
Author Information
- Publication Type:Journal Article
- MeSH: Drug-Related Side Effects and Adverse Reactions; epidemiology; Drugs, Chinese Herbal; adverse effects; Hospitals; Humans; Injections; Product Surveillance, Postmarketing; methods
- From: China Journal of Chinese Materia Medica 2011;36(20):2783-2785
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study Danhong injection adverse reactions (ADR) incidence, nature and clinical performance, provide the basis for the clinical safety of drugs.
METHODMulti-center, a large sample of hospitals focused on monitoring method.
RESULTDanhong injection ADR for the rapid onset and ease the quick recovery, the rate was 0. 682% , the newly discovered ADR constipation, sweating, tinnitus, irritability, joint disease, erythema, venous pain, phlebitis, local numbness, pain, weakness, gastrointestinal ulcer bleeding, vasospasm, cyanosis.
CONCLUSIONDanhong injection adverse reactions are type A adverse reactions occasionally, centralized monitoring of hospital medicine injection method is to carry out post-marketing safety re-evaluation of appropriate methods.
